Product catalog
contact us

    KCI BioTech (Suzhou) Inc.
    Tel:0512-69998806
    Ministry of Commerce:0512-69998806
    BD:
    North China:Mr. Xiong 15339988450
    East and South China:Ms. Gu 15378638068
    East China:Mr. Han 18914988667
    Central and Western regions: Ms. Xiang 15828112963
    Address: Building A2, Xinyang Industrial Park, No. 8 Yanghua Road, Suzhou Industrial Park

Key Model for Drug Development of Inflammatory Bowel Disease

  Inflammatory Bowel Disease (IBD) is an idiopathic inflammatory disease of the intestines involving the ileum, rectum, and colon. Clinical manifestations include diarrhea, abdominal pain, and even bloody stools. The disease includes ulcerative colitis (UC) and Crohn's disease (CD). Ulcerative colitis is a continuous inflammation of the mucosal and submucosal layers of the colon, and the disease usually involves the rectum first, gradually spreading to the whole colon; Crohn's disease can involve the whole digestive tract, and is a discontinuous whole-layer inflammation, with the most common sites of involvement being the terminal ileum, colon, and perianal area.
  We have established stable models of dextran sulfate (DSS)-induced inflammatory bowel disease and trinitrobenzene sulfonic acid (TNBS)-induced inflammatory bowel disease, which are suitable for preclinical inflammatory bowel disease drug research and new drug evaluation.
  If you have project needs and experience more of our professional services, please contact us.

Our services

Model classification

Model Name

Animal species

Inflammatory bowel disease

Model of dextran sulfate (DSS)-induced inflammatory bowel disease

Mice,rats,dog

Model of trinitrobenzene sulfonic acid (TNBS)-induced inflammatory bowel disease

Mice,rats


Case sharing


DSS induced mouse IBD model



TNBS induced rat IBD model


Next:Systemic lupus erythematosus